# Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome

> **NCT02656225** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine** · enrollment: 170 (estimated)

## Conditions studied

- Postpartum Anemia

## Interventions

- **DRUG:** Ejiao compound
- **DRUG:** Niferex

## Key facts

- **NCT ID:** NCT02656225
- **Lead sponsor:** The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2016-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656225, "Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02656225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*